Form 6-K Adagene Inc. For: Apr 17

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-
16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the Month of April 2026

 

Commission File Number: 001-39997

 

 

Adagene Inc.

 

 

4F, Building C14, No. 218

Xinghu Street, Suzhou Industrial Park

Suzhou, Jiangsu Province, 215123

People’s Republic of China

+86-512-8777-3632

(Address of principal executive offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F x   Form 40-F ¨

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	Adagene Inc.
	By:	/s/ Peter Luo
	Name:	Peter Luo
	Title:	Chief Executive Officer
Date: April 17, 2026

 

 

EXHIBIT INDEX

 

Exhibit		Description
99.1		Press release titled “Adagene Presents Two Posters at AACR 2026 with New Data Highlighting Muzastotug's Potential as a Backbone Combination Therapy for Multiple Tumor Types”

 

 

ATTACHMENTS / EXHIBITS

EXHIBIT 99.1

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• 1win VIP Community Member Ilia Topuria Sets for Historic UFC Freedom 250 Main Event
• Dr. Yorell Manon-Matos Scholarship for Healthcare Students Announces 2027 Application Cycle for Aspiring Medical Professionals Nationwide
• John Ramirez Jr. Scholarship for First-Generation Students Opens 2026 Application Cycle to Support Undergraduate Trailblazers Nationwide